Jove
Visualize
Contact Us

Related Experiment Videos

Targeting of somatic hypermutation.

Valerie H Odegard1, David G Schatz

  • 1VaxInnate Corporation, 300 George Street, Suite 311, New Haven, Connecticut 06511, USA.

Nature Reviews. Immunology
|July 27, 2006
PubMed
Summary

Somatic hypermutation (SHM) rapidly mutates immunoglobulin genes. Understanding how SHM targets these genes is crucial for preventing B-cell cancers caused by its rare, harmful mistargeting.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural and evolutionary divergence of the RAG1/1L N-terminal zinc-coordinating domain.

Cell reports·2026
Same author

Author Correction: Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia.

Nature immunology·2025
Same author

FAM72A promotes UNG2 degradation and mutagenesis in human cancer cells.

Scientific reports·2025
Same author

Transcription elongation factor ELOF1 is required for efficient somatic hypermutation and class switch recombination.

Molecular cell·2025
Same author

The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential tumorigenic activity.

Tumour virus research·2024
Same author

Transcription elongation factor ELOF1 is required for efficient somatic hypermutation and class switch recombination.

bioRxiv : the preprint server for biology·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Somatic hypermutation (SHM) is a process that introduces mutations into immunoglobulin genes at a high rate.
  • SHM is essential for adaptive immunity but requires precise targeting to immunoglobulin loci to maintain genomic integrity.
  • Mistargeting of SHM can lead to oncogene mutations and translocations, contributing to B-cell malignancies.

Purpose of the Study:

  • To review and reconcile existing research on the targeting mechanisms of somatic hypermutation.
  • To clarify the still-unclear process by which SHM is directed specifically to immunoglobulin genes.
  • To identify promising avenues for future research into SHM targeting.

Main Methods:

  • Literature review and synthesis of existing studies on somatic hypermutation targeting.
  • Analysis of conflicting and complementary findings regarding SHM mechanisms.
  • Identification of key research gaps and future directions.

Main Results:

  • The precise mechanism for targeting somatic hypermutation to immunoglobulin loci remains incompletely understood.
  • Conflicting data exists regarding the factors and pathways involved in SHM targeting.
  • Rare instances of SHM mistargeting are implicated in the pathogenesis of B-cell cancers.

Conclusions:

  • Further investigation is required to elucidate the complex targeting mechanisms of somatic hypermutation.
  • Resolving conflicting studies is essential for a comprehensive understanding of SHM regulation.
  • Understanding SHM targeting may offer insights into preventing B-cell malignancies.

Related Experiment Videos